专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 外观设计

USD977988S1 Tent water bag 有权
公开(公告)号：USD977988S1
公开(公告)日：2023-02-14
申请号：US29850233
申请日：2022-08-18
申请人： Weibo Wang
设计人： Weibo Wang

2. 发明申请

US20160145244A1 CERTAIN PROTEIN KINASE INHIBITORS 审中-公开
标题翻译：某些蛋白激酶抑制剂
公开(公告)号：US20160145244A1
公开(公告)日：2016-05-26
申请号：US14945426
申请日：2015-11-19
申请人： Weibo Wang , Meiyu Geng , Jian Ding , Xingdong Zhao , Jing Ai , Huajie Zhang , Xia Peng
发明人： Weibo Wang , Meiyu Geng , Jian Ding , Xingdong Zhao , Jing Ai , Huajie Zhang , Xia Peng
IPC分类号： C07D405/14
CPC分类号： C07D405/14
摘要： Provided are certain ALK inhibitors, pharmaceutical compositions thereof, and methods of use therefor.
摘要翻译：提供某些ALK抑制剂，其药物组合物及其用途。

3. 发明授权

US09154334B2 Apparatus management device, apparatus configuration method, and storage medium 有权
标题翻译：装置管理装置，装置配置方法和存储介质
公开(公告)号：US09154334B2
公开(公告)日：2015-10-06
申请号：US13349645
申请日：2012-01-13
申请人： Weibo Wang
发明人： Weibo Wang
IPC分类号： G06F15/177 , H04L12/64
CPC分类号： H04L12/6418
摘要： An apparatus management device, which is connected via a network to an apparatus, includes a storage unit configured to store a default value for a parameter of the apparatus and a table including coefficients associated with counter values indicating operational status of the apparatus; an apparatus information obtaining unit configured to obtain apparatus information including a counter value indicating the operational status from the apparatus; a parameter value calculation unit configured to obtain one of the coefficients that corresponds to the counter value in the obtained apparatus information by referring to the table, and to calculate an update value for the parameter of the apparatus by multiplying the default value by the one of the coefficients; and a setting unit configured to set the parameter of the apparatus at the update value.
摘要翻译：一种经由网络连接到装置的装置管理装置，包括：存储单元，被配置为存储所述装置的参数的默认值，以及包括与指示所述装置的操作状态的计数器值相关联的系数的表; 设备信息获取单元，被配置为从设备获取包括指示操作状态的计数器值的设备信息; 参数值计算单元，被配置为通过参考该表来获得所获得的装置信息中与计数器值对应的一个系数，并且通过将默认值乘以以下之一来计算装置的参数的更新值：系数; 以及设置单元，被配置为将所述装置的参数设置为所述更新值。

4. 发明申请

US20110190293A1 Quinazolinone Compounds as Anticancer Agents 审中-公开
标题翻译：喹唑啉酮化合物作为抗癌剂
公开(公告)号：US20110190293A1
公开(公告)日：2011-08-04
申请号：US13085048
申请日：2011-04-12
申请人： Weibo Wang , Liana M. Lagniton , Ryan N. Constantine , Manoj C. Desai
发明人： Weibo Wang , Liana M. Lagniton , Ryan N. Constantine , Manoj C. Desai
IPC分类号： A61K31/5377 , C07D239/91 , A61K31/517 , A61P35/00 , C07D413/04 , C07D413/06
CPC分类号： C07D401/06 , C07D239/90
摘要： Quinazolinone compounds, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the quinazolinone compounds, either alone or in combination with at least one additional therapeutic agent. Methods of using the quinazolinone compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases.
摘要翻译：喹唑啉酮化合物，其药学上可接受的盐和前药; 包括药学上可接受的载体和一种或多种喹唑啉酮化合物的组合物，单独或与至少一种另外的治疗剂组合。单独使用喹唑啉酮化合物或与至少一种其它治疗剂组合使用的方法可用于预防或治疗增殖性疾病。

5. 发明授权

US07553854B2 6-O-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling 有权
标题翻译： 6-O-取代的苯并恶唑和苯并噻唑化合物以及抑制CSF-1R信号传导的方法
公开(公告)号：US07553854B2
公开(公告)日：2009-06-30
申请号：US11737069
申请日：2007-04-18
申请人： James C Sutton , Marion Wiesmann , Weibo Wang , Mika Lindvall , Jiong Lan , Savithri Ramurthy , Anu Sharma , Elizabeth J. Mieuli , Liana M. Klivansky , William Lenahan , Susan Kaufman , Hong Yang , Simon C. Ng , Keith Pfister , Allan S. Wagman , Victoria Sung , Martin Sendzik
发明人： James C Sutton , Marion Wiesmann , Weibo Wang , Mika Lindvall , Jiong Lan , Savithri Ramurthy , Anu Sharma , Elizabeth J. Mieuli , Liana M. Klivansky , William Lenahan , Susan Kaufman , Hong Yang , Simon C. Ng , Keith Pfister , Allan S. Wagman , Victoria Sung , Martin Sendzik
IPC分类号： C07D215/00 , A61K31/44
CPC分类号： C07D413/12 , C07D417/12
摘要： Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.
摘要翻译：公开了苯并恶唑和苯并噻唑化合物及其立体异构体，互变异构体，溶剂合物，氧化物，酯和前药及其药学上可接受的盐。还公开了单独或与至少一种另外的治疗剂组合的化合物与药学上可接受的载体的组合，以及化合物单独或与至少一种另外的治疗剂组合的用途。这些实施方案可用于抑制细胞增殖，抑制肿瘤的生长和/或复分解，治疗或预防癌症，治疗或预防退行性骨疾病如类风湿性关节炎和/或抑制分子如CSF-1R。

6. 发明申请

US20080317744A1 Indole and Benzimidazole Derivatives 失效
标题翻译：吲哚和苯并咪唑衍生物
公开(公告)号：US20080317744A1
公开(公告)日：2008-12-25
申请号：US11665956
申请日：2005-10-14
申请人： Rustum S. Boyce , Yi Xia , Hongyan Guo , Kris G. Mendenhall , Annette O. Walter , Weibo Wang
发明人： Rustum S. Boyce , Yi Xia , Hongyan Guo , Kris G. Mendenhall , Annette O. Walter , Weibo Wang
IPC分类号： C07D401/12 , C07D209/14 , C07D403/12 , C07D235/04 , A61K31/4184 , A61K31/404 , A61K35/00 , A61K39/395
CPC分类号： C07D403/12 , C07D209/14 , C07D235/14 , C07D401/12 , C07D403/04 , C07D403/14
摘要： The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要翻译：本发明涉及新的吲哚和苯并咪唑化合物及其药学上可接受的盐，酯或前药，新化合物的组合物和药学上可接受的载体，以及新化合物的用途。本发明的化合物具有以下通式：

7. 发明授权

US07452996B2 Substituted quinoline derivatives 失效
标题翻译：取代喹啉衍生物
公开(公告)号：US07452996B2
公开(公告)日：2008-11-18
申请号：US11133509
申请日：2005-05-19
申请人： Weibo Wang , Ryan N. Constantine , Liana Marie Lagniton , Kenneth Bair
发明人： Weibo Wang , Ryan N. Constantine , Liana Marie Lagniton , Kenneth Bair
IPC分类号： C07D271/00
CPC分类号： C07D215/12 , C07D215/18
摘要： The present invention relates to new substituted quinoline compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要翻译：本发明涉及新的取代喹啉化合物及其药学上可接受的盐，酯或前药，新化合物与药学上可接受的载体的组合物，以及新化合物的用途。本发明的化合物具有以下通式：

8. 发明申请

US20080249112A1 Mitotic Kinesin Inhibitors 审中-公开
标题翻译：有丝分裂驱动蛋白抑制剂
公开(公告)号：US20080249112A1
公开(公告)日：2008-10-09
申请号：US11547834
申请日：2005-04-06
申请人： Weibo Wang , Ryan N. Constantine , Liana M. Lagniton
发明人： Weibo Wang , Ryan N. Constantine , Liana M. Lagniton
IPC分类号： C07D471/04 , A61K31/519 , A61P35/00
CPC分类号： C07D471/04 , C07D239/36
摘要： The present invention relates to compounds that are useful for treating cellular proliferative diseases, for treating disorders mediated, at least in part, by KSP, and for inhibiting KSP. The invention also related to pharmaceutical compositions comprising such compounds, methods of treating cancer by the administration of such compositions, and processes for the preparation of the compounds. Compounds of the invention have the following formula: formula (I).
摘要翻译：本发明涉及可用于治疗细胞增殖性疾病，用于治疗至少部分由KSP介导的病症和用于抑制KSP的化合物。本发明还涉及包含这些化合物的药物组合物，通过施用这些组合物治疗癌症的方法，以及制备化合物的方法。本发明化合物具有下式：式（I）。

9. 发明授权

US08735599B2 Substituted imidazole derivates 有权
标题翻译：取代的咪唑衍生物
公开(公告)号：US08735599B2
公开(公告)日：2014-05-27
申请号：US13613977
申请日：2012-09-13
申请人： Weibo Wang , Paul A. Barsanti , Xia Yia , Rustum S. Boyce , Sabina Pecchi , Nathan Brammeier , Megan C. Phillips , Kris Mendenhall , Kelly Wayman , Liana Marie Lagnition , Ryan N. Constantine , Hong Yang , Elizabeth Mieuli , Savithri Ramurthy , Elisa Jazan , Anu Sharma , Rama Jain , Sharadha Subramanian , Paul A. Renhowe , Kenneth W. Bair , David Duhl , Annette Walter , Tinya Abrams , Kay Huh , Eric Martin , Mark Knapp , Vincent P. Le
发明人： Weibo Wang , Paul A. Barsanti , Xia Yia , Rustum S. Boyce , Sabina Pecchi , Nathan Brammeier , Megan C. Phillips , Kris Mendenhall , Kelly Wayman , Liana Marie Lagnition , Ryan N. Constantine , Hong Yang , Elizabeth Mieuli , Savithri Ramurthy , Elisa Jazan , Anu Sharma , Rama Jain , Sharadha Subramanian , Paul A. Renhowe , Kenneth W. Bair , David Duhl , Annette Walter , Tinya Abrams , Kay Huh , Eric Martin , Mark Knapp , Vincent P. Le
IPC分类号： A61K31/4174 , C07D233/00 , C07D233/54
CPC分类号： C07D233/54 , C07D233/24 , C07D233/64 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/12 , C07D403/14 , C07D405/06 , C07D405/12 , C07D413/06 , C07D413/12 , C07D413/14 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D498/10
摘要： The present invention relates to new substituted imidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula:
摘要翻译：本发明涉及新的取代的咪唑化合物及其药学上可接受的盐，酯或前药，新化合物的组合物和药学上可接受的载体，以及新化合物的用途。本发明的化合物具有以下通式：

10. 发明申请

US20120225861A1 6-O-Substituted Benzoxazole and Benzothiazole Compounds and Methods of Inhibiting CSF-1R Signaling 有权
标题翻译： 6-O-取代的苯并恶唑和苯并噻唑化合物和抑制CSF-1R信号的方法
公开(公告)号：US20120225861A1
公开(公告)日：2012-09-06
申请号：US13453202
申请日：2012-04-23
申请人： James C. Sutton , Marion Wiesmann , Weibo Wang , Mika Lindvall , Jiong Lan , Savithri Ramurthy , Anu Sharma , Elizabeth J. Mieuli , Liana M Klivansky , William Lenahan , Susan Kaufman , Hong Yang , Simon C. Ng , Keith Pfister , Allan S. Wagman , Victoria Sung , Martin Sendzik
发明人： James C. Sutton , Marion Wiesmann , Weibo Wang , Mika Lindvall , Jiong Lan , Savithri Ramurthy , Anu Sharma , Elizabeth J. Mieuli , Liana M Klivansky , William Lenahan , Susan Kaufman , Hong Yang , Simon C. Ng , Keith Pfister , Allan S. Wagman , Victoria Sung , Martin Sendzik
IPC分类号： A61K31/4439 , C07D413/14 , A61K31/4545 , A61K31/5377 , C07D417/14 , A61P35/02 , A61P35/00 , A61P19/10 , A61P19/02 , A61P9/10 , A61P13/12 , C07D413/12 , A61K31/55
CPC分类号： C07D413/12 , C07D417/12
摘要： Benzoxazole and benzothiazole compounds and the stereoisomers, tautomers, solvates, oxides, esters, and prodrugs thereof and pharmaceutically acceptable salts thereof are disclosed. Compositions of the compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier, and uses of the compounds, either alone or in combination with at least one additional therapeutic agent are also disclosed. The embodiments are useful for inhibiting cellular proliferation, inhibiting the growth and/or metathesis of tumors, treating or preventing cancer, treating or preventing degenerating bone diseases such as rheumatoid arthritis, and/or inhibiting molecules such as CSF-1R.
摘要翻译：公开了苯并恶唑和苯并噻唑化合物及其立体异构体，互变异构体，溶剂合物，氧化物，酯和前药及其药学上可接受的盐。还公开了单独或与至少一种另外的治疗剂组合的化合物与药学上可接受的载体的组合，以及化合物单独或与至少一种另外的治疗剂组合的用途。这些实施方案可用于抑制细胞增殖，抑制肿瘤的生长和/或复分解，治疗或预防癌症，治疗或预防退行性骨疾病如类风湿性关节炎和/或抑制分子如CSF-1R。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式